Magnetic Resonance (MR) in Asthmatic Patients

This study has suspended participant recruitment.

(no funding)

Sponsor:

Information provided by:

University Health Network, Toronto

ClinicalTrials.gov Identifier:

NCT00188487

First received: September 12, 2005

Last updated: April 20, 2007

Last verified: April 2007

History of Changes

Purpose

Asthma is a disease of small airways. Affected areas have reduced lung ventilation causing reflex vasoconstriction. MR perfusion imaging of the lungs is a sensitive method of imaging zonal lung perfusion.

Condition	Intervention	Phase
Asthma	Device: magnetic resonance imaging (MRI) of the thorax	Phase 1


Study Type:	Interventional
Study Design:	Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic
Official Title:	MR Perfusion Imaging in Asthmatic Patients

Further study details as provided by University Health Network, Toronto:

Primary Outcome Measures:

The correlation of MR lung perfusion analysis with computed tomography (CT) findings and pulmonary function tests


Estimated Enrollment:	80
Study Start Date:	September 2005
Estimated Study Completion Date:	December 2005

Detailed Description:

A cohort of 70 Asthmatic Patients and 10 controls, both sets of subjects have HRCT, MRI/A of the Thorax, and Pulmonary Function Tests to correlate the degree of pulmonary dysfunction with findings on imaging tests.

Eligibility


Ages Eligible for Study:	16 Years and older (Child, Adult, Senior)
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

All asthmatic patients are eligible.

Exclusion Criteria:

Patients in whom MRI is contraindicated

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00188487

Locations


Canada, Ontario
Toronto General Hospital
Toronto, Ontario, Canada

Sponsors and Collaborators

University Health Network, Toronto

Investigators


Principal Investigator:	Narinder Paul, FRCP C	University Health Network, Toronto

More Information


ClinicalTrials.gov Identifier:	NCT00188487 History of Changes
Other Study ID Numbers:	05-0174
Study First Received:	September 12, 2005
Last Updated:	April 20, 2007
Health Authority:	Canada: Health Canada

ClinicalTrials.gov processed this record on September 28, 2016

To Top